Suppr超能文献

皮下植入式心律转复除颤器(S-ICD)植入术“技巧与窍门”

S-ICD Implantation "Tips and Tricks".

作者信息

Budrejko Szymon, Kempa Maciej, Przybylski Andrzej

机构信息

Department of Cardiology and Electrotherapy, Medical University of Gdansk, 80-210 Gdansk, Poland.

1st Department of Cardiology with the Acute Coronary Syndromes Subdivision, Clinical Provincial Hospital No. 2, 35-310 Rzeszow, Poland.

出版信息

Rev Cardiovasc Med. 2023 Jul 10;24(7):195. doi: 10.31083/j.rcm2407195. eCollection 2023 Jul.

Abstract

An implantable cardioverter-defibrillator (ICD) was developed to provide protection against sudden cardiac death. Despite being effective in terminating ventricular arrhythmias, traditional transvenous ICDs appeared over time to have certain limitations related to the need for vascular access and the presence of foreign material inside the circulatory system (namely lead failure and infections). A subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to overcome those limitations and to provide prevention against sudden cardiac death from outside the cardiovascular system. Utilization of that modern method of treatment is constantly increasing worldwide, and new centers incorporate implantation of that system in their portfolio. This review aims to present the most relevant issues related to S-ICD implantation procedure, based on experience of the authors and an extensive literature search.

摘要

植入式心脏复律除颤器(ICD)的研发旨在预防心源性猝死。尽管传统经静脉ICD在终止室性心律失常方面有效,但随着时间推移,其似乎存在一些与血管通路需求以及循环系统内存在异物(即导线故障和感染)相关的局限性。皮下植入式心脏复律除颤器(S-ICD)得以研发,以克服这些局限性,并从心血管系统外部预防心源性猝死。这种现代治疗方法在全球的应用正在不断增加,新的中心也将该系统的植入纳入其业务范围。基于作者的经验和广泛的文献检索,本综述旨在介绍与S-ICD植入手术相关的最相关问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6360/11266475/d70e3e5cb380/2153-8174-24-7-195-g1.jpg

相似文献

1
S-ICD Implantation "Tips and Tricks".
Rev Cardiovasc Med. 2023 Jul 10;24(7):195. doi: 10.31083/j.rcm2407195. eCollection 2023 Jul.
2
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.
5
Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
High Blood Press Cardiovasc Prev. 2020 Aug;27(4):291-297. doi: 10.1007/s40292-020-00394-x. Epub 2020 Jun 9.
6
[Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):27-31. doi: 10.1016/j.ancard.2014.08.018. Epub 2014 Sep 18.
7
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
J Am Coll Cardiol. 2023 Aug 1;82(5):383-397. doi: 10.1016/j.jacc.2023.05.034.
10
Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
J Am Coll Cardiol. 2016 Nov 8;68(19):2047-2055. doi: 10.1016/j.jacc.2016.08.044.

本文引用的文献

1
Subcutaneous implantable cardioverter-defibrillator therapy in Poland: Results of the Polish S-ICD Registry.
Kardiol Pol. 2023;81(5):455-462. doi: 10.33963/KP.a2023.0046. Epub 2023 Mar 5.
3
Subcutaneous implantable cardioverter-defibrillator implantation position predicts successful defibrillation in obese and non-obese patients.
J Interv Card Electrophysiol. 2025 Aug;68(5):1009-1015. doi: 10.1007/s10840-022-01462-z. Epub 2023 Jan 3.
4
Simultaneous Leadless Pacemaker and Subcutaneous ICD Implantation With Intraoperative Screening: Workflow in Two Patients.
JACC Case Rep. 2022 Nov 3;4(23):101535. doi: 10.1016/j.jaccas.2022.06.018. eCollection 2022 Dec 7.
6
Multicenter assessment of the outcomes of subcutaneous ICD implantation in patients with prior or future sternotomy.
Pacing Clin Electrophysiol. 2023 Feb;46(2):100-107. doi: 10.1111/pace.14615. Epub 2022 Nov 21.
9
10
Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: A meta-analysis.
Pacing Clin Electrophysiol. 2022 Dec;45(12):1409-1414. doi: 10.1111/pace.14603. Epub 2022 Oct 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验